Publication | Closed Access

A split-mouth, randomized, triple-blind, placebo-controlled study to analyze the pre-emptive effect of etoricoxib 120mg on inflammatory events following removal of unerupted mandibular third molars

InflammationAnti-inflammatoryInflammatory EventsPre-emptive EffectMedicinePharmacologyOrthognathic SurgeryPlacebo-controlled StudySurgeryMaxillofacial Surgery